News

New Ozempic alternative only needs to be taken once a month and leads to ‘substantial weight loss’
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
Medical Dialogues7h
Once-Monthly MariTide Shows Promising Weight Loss in Obesity and Type 2 Diabetes: Phase 2 Trial
MariTide is designed to combine the effects of glucagon-like peptide-1 (GLP-1) receptor activation with glucose-dependent ...
BioSpace9h
Analysts Home In on Safety as Novo, Lilly, Amgen Highlight Weight Loss Data at ADA
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
Zacks Investment Research on MSN22h
VKTX Initiates Phase 3 Study on Obesity Candidate VK2735
Viking Therapeutics VKTX announced that it has initiated the phase III VANQUISH program, evaluating the subcutaneous (SC) ...
Medical Marketing & Media2h
Rx Rundown: Royalty Pharma, Gilead Sciences, Abridge and more
Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.
Science Daily21h
Acid-busting diet triggers 13-pound weight loss in just 16 weeks
Swap steaks for spinach and you might watch the scale plummet. In a 16-week crossover study, overweight adults who ditched ...
The University of Alabama at Birmingham23h
Powerful new weight-loss drug helps patients shed 20 percent of body weight, study finds
W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...
STAT18h
Vaccine policy frays, CDC nominee in the hot seat, & obesity drug side effects
What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control ...